EyePoint Inc (EYPT)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$14.22

Buy

$14.27

arrow-up$0.58 (+4.25%)

Prices updated at 11 May 2026, 15:22 EDT

Prices minimum 15 mins delay

Prices in USD

EyePoint Pharmaceuticals Inc, formerly pSivida Corp develops tiny, sustained-release, drug delivery products designed to deliver drugs at a controlled and steady rate for months or years.

NASDAQ

0.11%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$14.25 - $13.76
	$19.11 - $5.30
	-
	1,145.69m
	-
	-
	95,105
	4.97
	1,085,195.60
	2.97
	82.83m
	US30233G2093
	-3.51
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.